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Abstract
Introduction
Lyme borreliosis (LB) is the most common tick transmitted disease in Europe. The diagnosis
of LB today is based on the patient´s medical history, clinical presentation and laboratory
findings. The laboratory diagnostics are mainly based on antibody detection, but in certain
conditions molecular detection by polymerase chain reaction (PCR) may serve as a
complement.
Aim
The purpose of this study was to evaluate the analytical sensitivity, analytical specificity and
concordance of eight different real-time PCR methods at five laboratories in Sweden, Nor-
way and Denmark.
Method
Each participating laboratory was asked to analyse three different sets of samples (refer-
ence panels; all blinded) i) cDNA extracted and transcribed from water spiked with cultured
Borrelia strains, ii) cerebrospinal fluid spiked with cultured Borrelia strains, and iii) DNA
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dilution series extracted from cultured Borrelia and relapsing fever strains. The results and
the method descriptions of each laboratory were systematically evaluated.
Results and conclusions
The analytical sensitivities and the concordance between the eight protocols were in general
high. The concordance was especially high between the protocols using 16S rRNA as the
target gene, however, this concordance was mainly related to cDNA as the type of template.
When comparing cDNA and DNA as the type of template the analytical sensitivity was in
general higher for the protocols using DNA as template regardless of the use of target gene.
The analytical specificity for all eight protocols was high. However, some protocols were not
able to detect Borrelia spielmanii, Borrelia lusitaniae or Borrelia japonica.
Introduction
Lyme borreliosis (LB) is the most common tick-borne disease in both Europe and Scandinavia,
with large variation from 1/100,000 to>100/100,000 cases per year between different countries
in Europe [1, 2]. The disease is caused by spirochetes belonging to the Borrelia burgdorferi
sensu lato (s.l.) complex, and clinical manifestations of LB may include erythema migrans
(EM), Lyme neuroborreliosis (LNB), acrodermatitis chronica atrophicans (ACA) and Lyme
arthritis (LA) [3].
The diagnosis of LB is based on a combination of the patient´s medical history, clinical
signs and symptoms and laboratory analyses. The microbiological analyses are mainly based
on indirect detection of B. burgdorferi s.l. infection through antibody detection by enzyme-
linked-immunosorbent assay (ELISA), which may be supplemented by immunoblot. Even
though the ELISA method is widely used, it exhibits biological limitations due to delay of anti-
body formation [4], cross-reactivity [5, 6] and high seroprevalence in healthy populations in
endemic areas [7–10]. Cultivation of the Borrelia spirochete is not used in clinical practice
since it requires a long incubation time, is time consuming and laborious, has poor sensitivity
in clinical samples (10–70%) and is susceptible to contamination [11, 12]. The need for a fast
and reliable diagnostic tool is high for both patients and health care providers. Direct detection
by PCR is a time efficient, reproducible, sensitive and specific method commonly used for
detection of bacteria and viruses. Even though PCR is not suitable as a primary diagnostic tool
for LB, probably due to the low numbers of spirochetes in most clinical cases, it may serve as a
supplement to serology for certain conditions as well as in confirmation and genotyping of the
infecting Borrelia spirochetes in suspected LB [11].
The clinical samples presenting the highest sensitivity of PCR for detection of B. burgdorferi
s.l. are skin biopsies from patients with EM (36–88%) and ACA (54–100%) [11] as well as
synovial fluid (SF) from LA patients (50–70%), while those with the lowest sensitivity are cere-
brospinal fluid (CSF) (10–30%) [12, 13] and blood (10–20%) [11, 13].
PCR diagnosis of LB is based on the detection of one or more B. burgdorferi s.l. target genes.
More than 20 target genes used for Borrelia detection (e.g., 16S rRNA, flaB, ospA and 5S-23S
intergenic spacer) have been published, but so far none of them has been widely implemented
in laboratory practice. To the best of our knowledge no previous studies have compared differ-
ent protocols on identical samples [14–16].
In 2011, a report regarding laboratory diagnostics of LB in Denmark, Finland, Norway and
Sweden was published. A total of 43 laboratories participated in the survey, of which six offered
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detection of Borrelia-specific DNA by PCR. However, among these six laboratories, real-time
PCR data was only available from five. Among a total of 582 samples extracted from CSF, skin
biopsies and SF, 2.4% of the CSF samples were positive while 13% of the skin biopsies and SF
samples generated positive results. This indicated that the most relevant material for PCR
detection of Borrelia is skin biopsies and SF [17]. However, in this study only the rate of posi-
tivity was calculated and a comparison of specificity and sensitivity between the laboratories
was not performed, which further supports the need for scrutiny of the PCR methods applied
in LB diagnostics.
The objective of this study was to evaluate the analytical sensitivity and specificity together
with the concordance of the real-time PCR methods currently in use in five laboratories in
Scandinavia. The study includes an evaluation of the extraction protocols, PCR assays and the
type of template (cDNA versus DNA) for the detection of B. burgdorferi s.l.
Materials and methods
Outline of the study
The study involved five laboratories (A-E) located in Scandinavia, including three clinical lab-
oratories and two research laboratories, using eight different PCR protocols (1–8) (Table 1 and
S1 Table). Two of the laboratories were located in Norway, two in Sweden and one in Den-
mark. Three blinded reference panels (described below) were sent to each laboratory, which
analysed the samples according to their own routine real-time PCR protocol. The panels were
also blinded for the coordinating laboratory. The results together with the method descriptions
were reported to the Laboratory of Clinical Microbiology, Division of Medical Diagnostics,
Region Jo¨nko¨ping County, Jo¨nko¨ping, Sweden (LCM, Sweden) for compilation.
Reference panels for the molecular analysis and detection of Borrelia
burgdorferi sensu lato
The reference panels of the study consisted of three different sample panels.
1. cDNA samples transcribed from total nucleic acid (NA) extracted from RNase-free water
spiked with known concentrations of cultured B. burgdorferi s.l. (B. afzelii Lu81, B. garinii
Lu59 and B. burgdorferi sensu stricto (s.s.) B31), including five negative controls (n = 20).
2. CSF samples spiked with known concentrations of B. burgdorferi s.l. bacteria (B. afzelii
Lu81, B. garinii Lu59 and B. burgdorferi s.s. B31) (n = 15).
3. DNA samples of known concentration extracted from nine B. burgdorferi s.l. species (B.
burgdorferi s.s. strains B31 and PBre, B. afzelii strains PKo and PVPM, B. garinii strains
PBr, PHei, P WudII, Pref and PLa, B. spielmanii PSigII, B. bavariensis PBi, B. bissetii PGeb,
B. lusitaniae Poti B2, B. valaisiana VS116 and B. japonica) and five specificity controls (B.
hermsii, B. miyamotoi, Treponema phagedenis and Leptospira) (n = 95).
The sample materials were shipped on dry ice. The participants were asked to keep the sam-
ples for panels I and III at -20˚C prior to analysis, the samples for panel II at -80˚C and to
avoid thawing and refreezing as this may affect the condition of the samples. Each sample was
analysed in duplicate by the participants.
Culture of Borrelia burgdorferi sensu lato strains (panels I and II)
All B. burgdorferi s.l. strains used for panels I and II were cultured at LCM, Sweden. The strains
were kindly provided by Professor Sven Bergstro¨m, Umeå University, Sweden. One mL of
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Table 1. Summary of the PCR methods used for detection of B. burgdorferi s.l. at five laboratories (A-E) in Scandinavia. Protocol 1 used LUX tech-
nology and protocol 2–8 used TaqMan technology.
Laboratory
Protocol Target
gene
Name Primer/
Probe
Sekvens (5’–3’) Final
concentration
(μM)1
Fragment
size
(bp)
Instrument2 Reference
A 1 16S
rRNA
B16S_FL Forward gac tcG TCA AGA
CTG ACG CTG
AGTC 3
0.200 131 CFX96 Wilhelmsson
et al. 2010 [18]
B16S_R Reverse GCA CAC TTA ACA
CGT TAG CTT CGG
TAC TAA C
0.200 (Bio-rad
Laboratories Inc.,
Hercules, US)
2 flaB flaBf Forward TCA AGA AAT AAT
GST ATT AAT GCT
GCTA A
0.600 98 ABI 7500 Jenkins et al.
2012 [19]
flaBr Reverse CCA GCA GCA TCA
TCA GAA GCT
0.600 (Applied
Biosystems Inc.,
flaBmA Probe TGT ATC CAC TAG
AAA GCT T
0.250 Carlsbad, US)
flaBm3B Probe TGT AAC CAC TAG
AAA GCT T
0.250
B 3 16S
rRNA
16S F Forward GCT GTA AAC GAT
GCA CAC TTG GT
0.500 69 LC480 Tsao et al. 2004
[16]
16S R Reverse GGC GGC ACA CTT
AAC ACG TTA G
0.500 (Roche
Diagnostics,)
16S TM Probe TTC GGT ACT AAC
TTT TAG TTA A
0.200 Basel, Switzerland)
4 ospA ospA F Forward ATA TTT ATT GGG
AAT AGG TCT AAT
AT
0.500 137 LC480 Goosken et al.
2006 [20]
ospA R Reverse CTT TGT CTT TTT
CTT TRC TTA CAA
G
0.500 (Roche
Diagnostics)
osp TM Probe AAG CAA AAT GTT
AGC AGC CTT GA
0.400
C 5 16S
rRNA
16SBOR_F Forward GGT CAA GAC TGA
CGC TGA GTC A
0.400 136 MxPro 3005P
Stratagene
Ornstein and
Barbour 2006
[21]
16SBOR_R Reverse GGC GGC ACA CTT
AAC ACG TTA G
0.400 (Agilent
Technologies Inc.,
16SBOR_P Probe TCT ACG CTG TAA
ACG ATG CAC ACT
TGG TG
0.100 Santa Clara, CA)
D 6 16S
rRNA
16SBOR-Fw Forward GGT CAA GAC TGA
CGC TGA GTC A
0.400 136 CFX96 Ornstein and
Barbour 2006
[21]
16SBOR-Rev Reverse GGC GGC ACA CTT
AAC ACG TTA G
0.400 (Bio-rad
Laboratories Inc.)
16SBOR-P Probe TCT ACG CTG TAA
ACG ATG CAC ACT
TGG TG
0.100
7 16S
rRNA
16SBor-sp-
Fw
Forward GCT GTA AAC GAT
GCA CAC TTG GT
0.900 69 CFX96 Tsao et al. 2004
[16]
16SBOR-Rev Reverse GGC GGC ACA CTT
AAC ACG TTA G
0.900 (Bio-rad
Laboratories Inc.)
16SBor-sp-P Probe TTC GGT ACT AAC
TTT TAG TTA A
0.225
(Continued )
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each strain was cultured in 14 mL Barbour-Stoenner-Kelly (BSK) II medium [22] supple-
mented with 6% rabbit serum (Sigma Aldrich, St. Louis, Missouri, US). B. afzelii Lu81 was cul-
tured at 35˚C for 8 days, B. garinii Lu59 at 37˚C for 7 days and B. burgdorferi s.s. B31 at 35˚C
for 6 days. The spirochetes were counted by phase-contrast microscopy. A 10-fold dilution
series ranging from 2000 to 0.2 spirochetes μL-1 was prepared in RNase-free water (GE Health-
care Life Science, Chicago, Illinois, US) for each strain. These dilutions were used to spike sam-
ples in panels I and II. The samples were spiked and aliquoted immediately after the dilution
series was prepared. The samples for panel I were extracted as described below, and the sam-
ples for panel II were placed at -80˚C.
Culture of Borrelia burgdorferi sensu lato strains and specificity controls
(panels III)
All B. burgdorferi s.l. strains were isolated from patient materials except for B. lusitaniae Poti
B2, B. valaisiana VS116 and B. japonica, which were all tick derived. The B. burgdorferi s.l.
strains and B. hermsii were cultured at 33˚C in modified Kelly-Pettenkofer (MKP) medium,
harvested at a density of 10^7 cells mL-1 by centrifugation at 20,000 x g for 20 min, washed
three times in 200 mL phosphate-buffered saline (PBS) pH 7.4 and resuspended in 200 mL
PBS as previously described [23]. Leptospira strains were cultured at 28˚C in Ellinghausen-
McCullough-Johnson-Harris (EMJH) medium (Leptospira Medium Base EMJH BD, DifcoTM
and Leptospira Enrichment EMJH DifcoTM, New Jersey, USA) as described before [24]. Trepo-
nema phagedenis was grown in Fluid Thioglycollate Medium (FTM) (BioMerieux, Marcy
l’Etoile, France) enriched with 10% rabbit serum (C. C. Pro GmbH, Germany) at 37˚C. B.
miyamotoi was grown in MKP medium with 50% human serum in a 6% CO2 atmosphere as
previously described [25]. Leptospira strains and T. phagedenis were harvested at a density of
10^7 cells mL-1 as described in the text above.
Extraction and reverse-transcription of nucleic acid (panel I)
A total of 5 μL of each dilution of each strain was used to spike 400 μL RNase-free water (GE
Healthcare Life), resulting in a final concentration ranging from 10^4 to 10^0 spirochetes per
sample. Total NA with no DNase treatment, was extracted at LCM, Sweden using a MagAt-
tract1 RNA Tissue Mini M48 kit (Qiagen, Hilden, Germany) and a BioRobot M48 Worksta-
tion (Qiagen) according to the manufacturer’s instructions with an insert volume of 400 μL.
Table 1. (Continued)
Laboratory
Protocol Target
gene
Name Primer/
Probe
Sekvens (5’–3’) Final
concentration
(μM)1
Fragment
size
(bp)
Instrument2 Reference
E 8 16S
rRNA
16S F Forward GCT GTA AAC GAT
GCA CAC TTG GT
1.250 69 StepOnePlus Tsao et al. 2004
[16]
16S R Reverse GGC GGC ACA CTT
AAC ACG TTA G
1.250 (Applied
Biosystems Inc.)
LD-probe Probe TTC GGT ACT AAC
TTT TAG TTA A
0.250
1 Some changes have been made in the concentration of primer pairs and probes in comparison to the original protocols.
2 Extraction volumes and platforms: 1 and 2) 300 μL centrifuged CSF extracted on Biorobot EZ1 Advanced XL ((Qiagen, Hilden, Germany), 3 and 4) 200 μL
centrifuged CSF extracted on Qiacube (Qiagen), 5) 500 μL uncentrifuged CSF extracted on NucliSENS® easyMag® (Biomerieux, Marcy-l’E´ toile, France),
and 6 and 7) 200 μL uncentrifuged CSF extracted on Biorobot EZ1 (Qiagen).
3 Bases in bold at the 5’ end of the B16S_FL primer correspond to additional bases added to create the hairpin loop structure.
https://doi.org/10.1371/journal.pone.0185434.t001
Molecular detection of Borrelia burgdorferi sensu lato
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The total NA was eluted in a volume of 50 μL RNAse-free water (GE Healthcare Life). Reverse-
transcribed NA (RTNA) synthesis was performed by using an Illustra ™ Ready-to-Go RT-PCR
beads kit (GE Healthcare, Amersham, Place, UK). Fifteen μL of the extracted NA was incubated
with 10 μL (0.25 μg μL-1) random hexamer primers (pd(N)6) at 97˚C for 5 min. The beads were
dissolved by adding 25 μL RNAse-free water (GE Healthcare Life), transferred to the NA/
primer solution and incubated at 42˚C for 30 min followed by 95˚C for 5 min, resulting in a
final volume of 50 μL. The RTNA was stored at -20˚C. The panel also included five negative
controls (three containing RNase-free water (GE Healthcare Life) and two containing DNA
purified from Escherichia coli). Since each sample was eluted in 50 μL, referring to 100% of the
sample in this study, and 15 μL per sample was used for the reverse-transcription of nucleic
acid, the amount of sample used was approximately two third of the total sample volume. This
means that each laboratory in panel I, but also in and II for laboratory A, has detected approxi-
mately 66.6% of the initial amount (10^4–10^0) of Borrelia spirochetes per sample (with the
assumption of 100% NA extraction) instead of 100% which would have been the case if the
reverse-transcription of nucleic acid had been done in triplicates using the total amount of the
eluted sample material. The cDNA was pooled and aliquoted. A total of 50 μL per sample was
sent out to the participating laboratories for amplification. Each laboratory was asked to use
5 μL per reaction.
Preparation of samples for nucleic acid extraction from cerebrospinal
fluid (panel II)
Five μL of each dilution of each strain (same dilution series as in panel I) was used to spike 1
mL of CSF, resulting in a final concentration ranging from 10^4 to 10^0 spirochetes mL-1. The
CSF used was obtained from the Clinical Chemistry Laboratory, Division of Medical Diagnos-
tics, Region Jo¨nko¨ping County, Jo¨nko¨ping, Sweden and consisted of pooled samples from
patients without CSF pleocytosis and without clinically suspected LNB. All the patients were
sampled for issues other than LNB (i.e. there were no clinical suspicions of LNB) and the sam-
ples were anonymized before use. The spiked CSF samples were stored at -80˚C until transpor-
tation to the participating laboratories. Each laboratory was asked to extract total NA with no
DNase treatment or DNA and analyse 5 μL per reaction by PCR according to their own proto-
col(s).
Preparation of DNA samples from cultured Borrelia species (panel III)
A total of 95 samples containing DNA of known concentration extracted from 15 cultured
B. burgdorferi s.l. strains (B. burgdorferi s.s. strains B31 and PBre, B. afzelii strains PKo
and PVPM, B. garinii strains PBr, PHei, P WudII, Pref and PLa, B. spielmanii PSigII, B.
bavariensis PBi, B. bissetii PGeb, B. lusitaniae Poti B2, B. valaisiana VS116 and B. japonica)
were analysed by the five participating laboratories. The panel also included five specific-
ity controls containing two relapsing fever strains (B. hermsii and B. miyamotoi), Trepo-
nema phagedenis and Leptospira, spirochetes closely related to B. burgdorferi s.l., in a final
concentration of 2000 spirochetes μL-1.
Extraction of DNA was performed using a Maxwell1 16 LEV Blood DNA Kit (Promega Corpo-
ration, Madison, USA) on the Maxwell1 16 Instrument (Promega) as recommended by the manu-
facturer. DNA concentration was measured by NanoDrop™ 1000 Spectrophotometer (Thermo
Scientific, Massachusetts, USA), and 15 mL of a solution containing 2000 organisms μL-1 was pro-
duced by adding 0.01 M Tris-buffer pH 8.0 molecular biology grade (AppliChem Panreac, Darm-
stadt, Germany). A 10-fold dilution series corresponding to 200–0.02 Borrelia spirochetes μL-1 was
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produced, and aliquots of 50 μL per dilution were stored frozen at -80˚C until transportation to the
participating laboratories.
Detection of Borrelia burgdorferi sensu lato by real-time PCR at the
participating laboratories
The samples in panels I-III were analysed by the participating laboratories according to the
protocols presented in Table 1 and S1 Table. Each laboratory based their protocol on real-time
PCR, with seven of eight protocols using TaqMan technology, and one of the eight used LUX
technology. Seven of eight protocols detected the chromosomal target genes 16S rRNA (n = 6)
and flaB (n = 1) while one detected the plasmid target gene ospA. Three of eight protocols (pro-
tocols 3, 7 and 8) were based on Tsao et al. 2004 [16] and two of eight protocols (protocols 5
and 6) were based on Ornstein et al. 2006 [21] (Table 1). The protocols detecting the target
gene 16S rRNA (protocols 1, 3 and 5–8) are further referred to as 16S rRNA PCR protocols,
and the protocols detecting the target genes ospA and flaB (protocols 2 and 4) are further
referred to as non-16S rRNA PCR protocols.
Statistics
The analytical sensitivity was assessed for protocols 1–8 as well as for the 16S rRNA PCR pro-
tocols in panels I–III using dilutions of cultured Borrelia species. Analytical specificity was
assessed using controls spiked with E. coli and RNase-free water as well as two relapsing fever
strains (B. hermsii and B. miyamotoi), Treponema phagedenis and Leptospira. The R-software
was used for calculation of the 95% binomial confidence interval (CI) using the command
binom.confint in package binom, choosing the Wilson method, which is a choice when CIs
are close to the limits of zero or one.
Results
Real-time PCR of cDNA from spiked water samples (panel I)
The concentrations given as unit mL-1 in the cDNA panel I refer to the initial concentration of
spirochetes prior to total NA extraction. As well, the amount of cDNA of each sample will be
influenced by the level of mRNA expression of the target genes in the strains used. The results
presented full concordance between the eight protocols down to 10^3 spirochetes mL-1 for B.
afzelii Lu81 and B. burgdorferi s.s. B31 and full concordance as far as 10^1 spirochetes mL-1 for
B. garinii Lu59 (Table 2 and S2 Table). At target concentration of 10^2 spirochetes mL-1 or
below the ability to detect Borrelia cDNA varied between the protocols, especially for the non-
16S rRNA PCR protocols, which had lower analytical sensitivity for B. afzelii Lu81 and B. burg-
dorferi s.s. B31. However, the 16S rRNA PCR protocols showed full concordance between
10^4 and 10^1 spirochetes mL-1 for all the three Borrelia genospecies (Table 2 and S2 Table).
At a concentration of 10^0 spirochetes mL-1, only one sporadic positive result was found, as
would be expected. All negative controls containing RNase-free water (GE Healthcare Life) or
E. coli (n = 40) were correctly identified as negative by all protocols, except for protocol 8
which gave a positive result for one of the negative controls (Table 2 and S2 Table). Thus, the
analytical specificity of the PCR protocols taken together with five samples each was 95.7%
(95% CI 87–100%).
Real-time PCR of spiked cerebrospinal fluid samples (panel II)
The results from the seven protocols (panel II was not analysed by protocol 8 due to lack of
resources) presented full concordance down to 10^3 spirochetes mL-1 for B. afzelii Lu81 and
Molecular detection of Borrelia burgdorferi sensu lato
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B. burgdorferi s.s. B31 and full concordance down to 10^2 spirochetes mL-1 for B. garinii Lu59
(Table 3 and S3 Table). The unit mL-1 in panel II refers to the original concentration prior to
extraction, assuming 100% exchange and the use of the entire sample volume (1 mL). At target
concentrations of 10^2 spirochetes mL-1 or below the ability to detect Borrelia cDNA or DNA
varied between the protocols, especially for the two protocols extracting total NA (Laboratory
A). However, the protocols extracting DNA showed full concordance down to 10^2 spiro-
chetes mL-1 for all three Borrelia genospecies (Table 3 and S3 Table).
Real-time PCR of samples with known concentration of DNA (panel III)
All eight protocols found concordant positive results down to 2 spirochetes μL-1 for the strains B.
burgdorferi s.s. Pbre; B. afzelii PKo and PVPM; B. garinii PBr, PHei, PWudII, PRef and Pla; B.
bavariensis Pbi; B. bissetii PGeb; and B. valaisiana VS116 (Table 4 and S4 Table). For B. burgdor-
feri s.s. B31 the protocols found concordant positive results down to>1 spirochete μL-1. The sam-
ple containing B. spielmanii PSigII showed concordant positive results down to 2 spirochetes μL-1
for all protocols except for one non-16S rRNA PCR protocol (protocol 4). The B. lusitaniae Poti
B2 samples yielded concordant positive results down to 2 spirochetes μL-1 for all protocols except
for the two used by Laboratory B (protocol 3 and 4), which did not detect it. B. japonica yielded
concordant positive results down to 20 spirochetes μL-1 for three of the 16S rRNA PCR protocols
(protocol 1, 5 and 6) and negative results at all dilutions for the remaining protocols. B. hermsii
Table 2. Results from panel I consisting of cDNA transcribed from total nucleic acid extracted from RNase-free water spiked with different concen-
trations of B. afzelii Lu81, B. garinii Lu59 and B. burgdorferi s.s. B31.
Laboratory A Laboratory B Laboratory C Laboratory D Laboratory E
16S rRNA flaB 16S rRNA ospA 16S rRNA 16S rRNA 16S rRNA 16S rRNA
Strain Concentration4,5 Protocol 1 Protocol 2 Protocol 3 Protocol 4 Protocol 5 Protocol 6 Protocol 7 Protocol 8
B. afzelii Lu81 10^4 + + + + + + + +
10^3 + + + + + + + +
10^2 + - + + + + + +
10^1 + - + - + + + +
10^0 - - - - - - - -
B. garinii Lu59 10^4 + + + + + + + +
10^3 + + + + + + + +
10^2 + + + + + + + +
10^1 + + + + + + + +
10^0 - - - - - - - -
B. burgdorferi s.s. B31 10^4 + + + + + + + +
10^3 + + + + + + + +
10^2 + - + - + + + +
10^1 + - + - + + + +
10^0 + - - - - - - -
E.coli J1 50 - - - - - - - -
50 - - - - - - - -
RNase-free water - - - - - - - +
- - - - - - - -
- - - - - - - -
4 The unit for the Borrelia strains is spirochetes mL-1 while the unit for E. coli is ng μL-1.
5 The unit mL-1 in panel I corresponds to the original concentration prior to extraction, assuming 100% exchange, and not the expected concentration after
cDNA synthesis.
https://doi.org/10.1371/journal.pone.0185434.t002
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yielded positive results for 2000 spirochetes μL-1 in all protocols except for the non-16S rRNA
PCR protocols (protocols 2 and 4). B. miyamotoi yielded positive results for 2000 spirochetes μL-1
for all protocols except for one of the non-16S rRNA PCR protocols (protocol 4). Twenty-three
of twenty-four samples spiked with Leptospira or T. phagedenis, were negative. The analytical
specificity of the PCR protocols taken together was 96% (95% CI 80–99%).
Discussion
In this study we compared analytical sensitivity, analytical specificity and concordance
between eight protocols for detecting B. burgdorferi s.l. by real-time PCR assays at five labora-
tories in Scandinavia. The concordance and analytical sensitivity between the protocols is gen-
erally high. However, the results demonstrate the importance of the choice of target gene as
well as type of template (DNA/cDNA), especially regarding 16S rRNA in relation to cDNA. A
previous study including participants from 18 countries comparing different reverse transcrip-
tase (RT)-PCR protocols for detection of tick-borne encephalitis virus (TBEV) showed that
only 2 of 23 participants correctly identified all samples in the study, which concluded that
there is a need for improvement in the sensitivity and specificity of molecular assays for the
virus [26].
PCR may be a complementary diagnostic tool in spinal fluid from LNB patients in early dis-
ease when antibodies are not yet developed [11]. The method could be applicable in situations
when the serological method is unable to distinguish between an acute and previous infection,
similar to that in skin biopsies from EM where active and viable Borrelia spirochetes persist in
IgG positive patients or in LA patients where DNA from dead bacteria may persist for months
in synovial fluid of IgG positive patients [27]. However, clear recommendations for clinical use
of PCR have not yet been proposed. Although PCR has high analytical sensitivity, bacterial
Table 3. Results from panel II consisting of cerebrospinal fluid spiked with different concentrations of B. afzelii Lu81, B. garinii Lu59 and B. burg-
dorferi s.s. B31. Protocol 8 was excluded due to lack of resources.
Laboratory A Laboratory B Laboratory C Laboratory D
cDNA cDNA DNA DNA DNA DNA DNA
Strain Concentration6, 7 Protocol 1 Protocol 2 Protocol 3 Protocol 4 Protocol 5 Protocol 6 Protocol 7
B. afzelii Lu81 10^4 + + + + + + +
10^3 + + + + + + +
10^2 - - + + + + +
10^1 - - + + - - -
10^0 - - - - - - -
B. garinii Lu59 10^4 + + + + + + +
10^3 + + + + + + +
10^2 + + + + + + +
10^1 - - - - + + +
10^0 - - + + - + +
B. burgdorferi s.s. B31 10^4 + + + + + + +
10^3 + + + + + + +
10^2 - - + + + + +
10^1 - - - - - - -
10^0 - - - - - - -
6 The unit for the Borrelia strains is spirochetes mL-1.
7 The unit mL-1 in panel II corresponds to the original concentration prior to extraction, assuming 100% exchange.
https://doi.org/10.1371/journal.pone.0185434.t003
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Table 4. Results from panel III consisting of DNA extracted from 15 Borrelia strains and five specificity controls containing two relapsing fever
strains (B. hermsii and B. miyamotoi), Treponema phagedenis and Leptospira.
Laboratory A Laboratory B Laboratory C Laboratory D Laboratory E
Strains Concentration8 Protocol 1 Protocol 2 Protocol 3 Protocol 4 Protocol 5 Protocol 6 Protocol 7 Protocol 8
B. burgdorferi s.s. B31 10^4–10^0 + + + + + + + +
10^-1 - - - + + + - +
B. burgdorferi s.s. PBre 10^4–10^1 + + + + + + + +
10^0 - + + + + - + +
10^-1 - - - - + - - -
B. afzelii PKo 10^4–10^1 + + + + + + + +
10^0 - + + + + + + +
10^-1 - - + + + - + -
B. afzelii PVPM 10^4–10^1 + + + + + + + +
10^0 - + + + + + + +
10^-1 - + + + + - - -
B. garinii PBr 10^4–10^1 + + + + + + + +
10^0 + + + + + + - +
10^-1 - - + + + + - -
B. garinii PHei 10^4–10^1 + + + + + + + +
10^0 - - + + + + + +
10^-1 - - - - - - - -
B. garinii PWudll 10^4–10^1 + + + + + + + +
10^0 - - + + + + + +
10^-1 - - + + + - - -
B. garinii PRef 10^4–10^1 + + + + + + + +
10^0 - + + + + + + +
10^-1 - - - + - + + +
B. garinii PLa 10^4–10^1 + + + + + + + +
10^0 + + + - + + - +
10^-1 - - - - - + - +
B. spielmanii PSigII 10^4 + + + - + + + +
10^3 + + + - + + + +
10^2 + + + - + + + +
10^1 + + + - + + + +
10^0 - - - - + + + +
10^-1 - - - - - - - -
B. bavariensis PBi 10^4–10^1 + + + + + + + +
10^0 - + + + + + + -
10^-1 - - - - - - - -
B. bissetii PGeb 10^4–10^1 + + + + + + + +
10^0 - + + + + - + +
10^-1 - - - + + - - +
B. lusitaniae Poti B2 10^4 + + - - + + + +
10^3 + + - - + + + +
10^2 + + - - + + + +
10^1 + + - - + + + +
10^0 - + - - + + + +
10^-1 - - - - + - + +
B. valaisiana VS116 10^4–10^1 + + + + + + + +
(Continued )
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DNA may be detected only if this is present in the patient material in sufficient concentration;
thus, the clinical sensitivity has been found to vary. Hence, optimization of the methods is cru-
cial. As the B. burgdorferi s.l. spirochetes can be found in very low numbers, the method is of
limited value as a positive result is rare due to lack of bacteria in the sample, and a negative
result cannot exclude infection. To improve both the analytical sensitivity and specificity of the
PCR methods there are several aspects that are important to take into consideration, e.g. the
target gene, the method of extraction, the type of template (total NA/cDNA/DNA), the primer
and probe sequences, the PCR conditions and the thermocycler [11]. For instance, it is essen-
tial to use a target gene that is genetically stable [28], since loss or alteration of the target
sequence may lead to loss of reactivity.
The results from panel I (Table 2 and S2 Table) in the present study demonstrate the impor-
tance of selecting a target gene in correlation with cDNA as the type of template. Laboratory A
(protocols 1 and 2) and laboratory B (protocols 3 and 4) used two different target genes; 16S
rRNA versus flab and 16S rRNA versus ospA, respectively, for detection of B. burgdorferi s.l.
The results showed different detection limits between the protocols in favor of the 16S rRNA
PCR protocols when using cDNA as the type of template. Previous studies have shown that the
heterogeneous plasmid target ospA is present in multiple copies in each bacterium, indicating
that the sensitivity is higher than for the single-copy chromosomal target gene 16S rRNA [29,
30]. However, if the variability of existing copies of the gene within the Borrelia genus is high
one must not be misled to think that the sample contains a higher number of spirochetes then
it actually does. In clinical samples this may be a pitfall and therefore, in cases were quantifica-
tion of the Borrelia spirochetes is of interest, it is preferable to use a gene with a consistent
copy number in the bacteria genome. The results from panel I consisting of cDNA as type
of template demonstrate higher analytical sensitivity for the 16S rRNA PCR protocols com-
pared to the non-16S rRNA PCR protocols in combination with cDNA. This finding may be
explained by the fact that since the rRNA is one of the most abundant molecules in the bacte-
rial cell, there is potential for lowering the detection limit by more than one order of magni-
tude compared to genomic or plasmid DNA targets. Previous studies have shown that 16S
rRNA is more sensitive than assays based on the plasmid gene ospA [21]. However, there are
Table 4. (Continued)
Laboratory A Laboratory B Laboratory C Laboratory D Laboratory E
Strains Concentration8 Protocol 1 Protocol 2 Protocol 3 Protocol 4 Protocol 5 Protocol 6 Protocol 7 Protocol 8
10^0 - + + + + + + +
10^-1 - - + + - + - -
B. japonica 10^4 + - - - + + - -
10^3 + - - - + + - -
10^2 + - - - + + - -
10^1 - - - - + + - -
10^0 - - - - + - - -
10^-1 - - - - - - - -
B. hermsii 10^4 + - + - + + + +
B. miyamotoi 10^4 + + + - + + + +
T. phagedenis 10^4 - - - - - - - -
Leptospira 10^4 - - - - + - - -
Leptospira 10^4 - - - - - - - -
8The amount of Borrelia spirochetes in 5 μL.
https://doi.org/10.1371/journal.pone.0185434.t004
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some drawbacks to using RNA instead of DNA, such as additional cost in reagents and labour
as well as high susceptibility of RNA to degradation and nucleases during extraction and stor-
age. Despite the differences in detection limit between the non-16S rRNA PCR protocols, the
concordance between the 16S rRNA PCR protocols was high, wherein protocols 5 and 6
according to Ornstein et al. 2006 [20] and protocols 3, 7 and 8 according to Tsao et al. 2004
[16] each used the same set of primer pairs and probes. However, based on the use of cDNA,
we can argue only that cDNA from cultured Borrelia is more reliably detected by the 16S
rRNA PCR protocols. The analytical sensitivity in terms of detectable genome copies remains
unclear. In this context it would have been of high interest to establish the analytical sensitivity
in the same type of samples but without cDNA transcription since the possible positive effect
of the initial cDNA transcription might have become obvious. However, this could not be per-
formed, since it was preferable to keep the study less laborious and less expensive for each par-
ticipating part in order to make it feasible for as many laboratories as possible to participate in
the study.
However, the project was set up so that we could conclude regarding this issue in panel III,
containing DNA samples at different concentrations analyzed by the five participating labora-
tories. In panel III we saw that the analytical sensitivity is high and not affected by the choice
of target gene, unlike in panel I where we find an increase sensitivity for the PCR protocols
based on the target gene 16S rRNA and when cDNA was used as the type of template. We are
convinced that the same conclusions would have been made if we had extracted and analyzed
the samples in panel I for DNA and compared it with the results generated by analysis of
cDNA.
Since no quantitative PCR was performed the exact yield of total NA after extraction and
cDNA after transcription is unknown, which may be considered a weakness in panel I as well
as for protocols 1 and 2 in panel II. However, since most of the protocols were able to detect
down to 10^1 spirochetes per mL-1, we assume that the yield was acceptable.
Panel II (Table 3 and S3 Table) demonstrates the importance of selecting the type of tem-
plate in relation to the target gene, since the PCR results are highly dependent on this. Extract-
ing total NA followed by cDNA-synthesis will theoretically result in higher numbers of targets
per cell since the extraction from each bacterium will result in a high amount of specific RNA
molecules together with DNA. Each sample will contain a mix of reverse-transcribed NA and
extracted DNA since no DNase treatment was performed. When comparing the results gener-
ated from the different protocols we observed that the limit of detection (LOD) for the samples
tested was the same within each laboratory regardless of type of target gene and that the LOD
varies between the different laboratories depending on type of template. However, the analyti-
cal sensitivity in panel II was higher for the protocols analysing DNA compared to the proto-
cols analysing cDNA, where the analytical sensitivity was lower. This strongly indicates the
importance of pre-analytical factors other than extraction and type of template, such as sample
volume, centrifugation of sample versus no centrifugation of sample, centrifugation speed and
time, but also the use of fresh versus frozen samples, which may influence the analytical sensi-
tivity and specificity. These parameters would be highly interesting to investigate in a further
study. A comparison between the 16S PCR protocols (excluding protocol 1 that extracted total
NA), wherein protocols 5 and 6 according to Ornstein et al. 2006 [20] and protocols 3 and 7
according to Tsao et al. 2004 [16] each used the same set of primer pairs and probes, presented
full concordance down to at least 10^2 spirochetes mL-1. However, protocol 3 was not able
to detect the B. garinii Lu59 strain in the 10^1 spirochetes mL-1 dilution, but it was able to
detect 10^0 spirochetes mL-1. This may be a result of the high dilution in 10^1–10^0 spiro-
chetes mL-1, which may affect the reproducibility. However, it may also be a result of sample
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mix-up or contamination since the results from the 16S rRNA PCR protocol (protocol 3) were
reproducible for ospA (protocol 4).
In panel III (Table 4 and S4 Table), containing extracted DNA from nine Borrelia species,
the analytical sensitivity of the different target genes within any single laboratory (16S rRNA
versus flaB or 16S rRNA versus ospA) was in generally high and comparable. However, we did
not see any relation between DNA and any specific target gene like in panel I. Protocols 1, 5
and 6 were designed in silico to detect a segment of the 16S rRNA gene DNA sequence present
in practically all species of borreliae including B. afzelii, B. garinii, B. burgdorferi s.s., B. valaisi-
ana, B. lusitaniae, B. spielmanii, B. miyamotoi and B. hermsii. Therefore, all of these species in
panel III could be detected with these protocols. The primers in protocol 3, 7 and 8 were
designed in silico to amplify a segment of the 16S rRNA gene in most members of the B. burg-
dorferi s.l. complex and in the relapsing fever borreliae. Laboratory A (protocol 2) did not
detect B. japonica or B. hermsii when the gene flaB was targeted. The reason for this result
could be due to mismatches at the primer binding site. The flaB gene of B. japonica has two
mismatches within the binding site of the forward primer. Likewise, the flaB gene of B. hermsii
has four mismatches at the binding site of the reverse primer, two within the primer sequence
and two at the 3’ terminus, and four mismatches at the binding site for the forward primer.
However, the PCR assays were probably not designed to detect “relapsing fever” borreliae.
Laboratory B (protocol 4) was not able to detect B. spielmanii PSigII, B. lusitaniae Poti B2, B.
japonica, B. hermsii or B. miyamotoi when the ospA gene was targeted. In addition to this, labo-
ratory B (protocol 3) was not able to detect B. lusitaniae Poti B2 or B. japonica, in contrast to
laboratory D (protocol 7) and laboratory E (protocol 8), which detected B. lusitaniae Poti B2 as
positive using the same set of primer pairs and probes, all amplifying the 16S rRNA target
gene. However, as in protocol 3, these protocols were not able to detect B. japonica (Table 4
and S4 Table). Further investigation of the binding site of the primers revealed two mis-
matched bases between the reverse primer and its binding site on the template. One of the two
mismatched bases is located at the 3’ terminus and these mismatches may explain the failure of
B. japonica detection by protocols 3, 7 and 8. Regarding the B. lusitaniae strain, protocols 7
and 8 were both able to detect it even though one mismatched base appears in the probe target
sequence. Regarding B. hermsii and B. miyamotoi, protocols 3, 7 and 8 should theoretically not
be able to detect the two species since there are three mismatched bases and one extra base in
the probe targeting sequence. This finding may be a result of the high target gene concentra-
tion. However, all three laboratories, B, D and E were able to detect the two species. The unex-
pected detection of Leptospira DNA with protocol 5 may be a result of possible carry-over
contamination. In practice, all 16S PCR-based tests without DNA sequencing of the PCR
amplicon for validation are prone to generate this kind of error.
Previous studies have shown that ospA is highly variable in European strains and that detec-
tion of the gene is dependent on the design of primers and probes [28], which may explain the
results for protocol 4. However, it is unclear why some genospecies were not detected by the
16S rRNA protocols, even though there were theoretically full match at the binding sites for
forward and reverse primer for all genospecies, except for the two mismatches in the reverse
primer of B. japonica. This result illustrates the importance of including positive controls, par-
ticipating in quality programmes and optimization of primer pairs and probes in order to
detect newly discovered pathogenic species such as B. spielmanii.
The principal aim of the study was to compare and evaluate the real-time PCR protocols in
the participating laboratories as processes rather than to perform a detailed technical evalua-
tion of effectiveness. Furthermore, the included samples consisted of cultured bacteria of
known origin to ensure high quality material for comparison of PCR assays. To further assess
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the laboratory procedures and interpretation of results in clinical practice and research, it
would have been desirable to complement the real-time PCR results with sequencing results.
The data from the present study may contribute to the development of validation criteria
for PCR methods for the molecular detection of B. burgdorferi s.l. in clinical samples in Europe.
It is recommended that a PCR method should at least be able to detect B. afzelii, B. garinii and
B. burgdorferi with the same sensitivity. However, it is also desirable to have a method that is
able to detect other Borrelia species such as B. spielmanii, B. bissetii and B. lusitaniae, as human
pathogenicity is indicated. By continuous control and optimization of primer and probe speci-
ficity it is possible to find new genotypes and mutations which may be highly important.
Conclusion
In conclusion, we show high analytical sensitivity, analytical specificity and concordance
between the eight real-time PCR protocols. Together with the low cross-reactivity for species
closely related to Borrelia, the findings of this study indicate that the analytical sensitivity prob-
lem in CSF samples is not associated with the type of template. To increase the analytical sensi-
tivity, the pre-analytical parts of the methods must be further evaluated and optimized.
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